Search Results - "Croghan, G. A."

Refine Results
  1. 1

    Environmental tobacco smoke exposure in women with lung cancer by de Andrade, M, Ebbert, J.O, Wampfler, J.A, Miller, D.L, Marks, R.S, Croghan, G.A, Jatoi, A, Finke, E.E, Sellers, T.A, Yang, P

    Published in Lung cancer (Amsterdam, Netherlands) (01-02-2004)
    “…Background: Investigations on environmental tobacco smoke (ETS) exposure that include source intensity, childhood exposure, and association with histologic…”
    Get full text
    Journal Article
  2. 2

    A randomized trial of naltrexone for smoking cessation by Wong, Gilbert Y., Wolter, Troy D., Croghan, Gary A., Croghan, Ivana T., Offord, Kenneth P., Hurt, Richard D.

    Published in Addiction (Abingdon, England) (01-08-1999)
    “…Aims. To evaluate the efficacy and safety of orally administered naltrexone, alone or in combination with nicotine patches, as a treatment for cigarette…”
    Get full text
    Journal Article
  3. 3

    Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms by HURT, R. D, OFFORD, K. P, CROGHAN, I. T, CROGHAN, G. A, GOMEZ-DAHL, L. C, WOLTER, T. D, DALE, L. C, MOYER, T. P

    Published in Psychopharmacologia (01-11-1998)
    “…Nicotine nasal spray and nicotine gum have been found to be effective in relieving nicotine withdrawal symptoms. In this randomized single-blind study, 91…”
    Get full text
    Journal Article
  4. 4

    Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels by Hurt, R D, Dale, L C, Croghan, G A, Croghan, I T, Gomez-Dahl, L C, Offord, K P

    Published in Mayo Clinic proceedings (01-02-1998)
    “…To determine the extent of side effects during the initial use of nicotine nasal spray for smoking cessation. We performed a one-sample, noncomparative,…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Malignant phyllodes tumor of prostate by Löpez-Beltran, A, Gaeta, J F, Huben, R, Croghan, G A

    Published in Urology (Ridgewood, N.J.) (01-02-1990)
    “…A case of malignant phyllodes tumor of the prostate, with clinical course of recurrence and pulmonary metastasis is described in a thirty-eight-year-old man…”
    Get more information
    Journal Article
  7. 7

    Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study by Lopez-Beltran, A, Croghan, G A, Croghan, I, Matilla, A, Gaeta, J F

    Published in American journal of clinical pathology (01-07-1994)
    “…Pathologic grade and stage, immunohistochemical analysis of eight cell and tumor markers, and DNA ploidy were studied in 36 cases of bladder cancer to…”
    Get more information
    Journal Article
  8. 8

    Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler by Hurt, Richard D., Croghan, Gary A., Wolter, Troy D., Croghan, Ivana T., Offord, Kenneth P., Williams, Gary M., Djordjevic, Mirjana V., Richie, John P., Jeffrey, Alan M.

    Published in Nicotine & tobacco research (01-11-2000)
    “…The aim of the study was to determine if smoking reduction using a nicotine inhaler in heavy cigarette smokers who wanted to reduce but not stop smoking…”
    Get full text
    Journal Article
  9. 9

    Prognostic factors in survival of bladder cancer by Lopez-Beltran, A, Croghan, G A, Croghan, I, Huben, R P, Mettlin, C, Gaeta, J F

    Published in Cancer (15-08-1992)
    “…Clinical and pathologic data of 36 patients with transitional cell carcinoma of the bladder were investigated to determine the significance on patient survival…”
    Get more information
    Journal Article
  10. 10

    Experimental Tumoricidal Effects of Monoclonal Antibody against Solid Breast Tumors by Capone, Patrick M., Papsidero, Lawrence D., Croghan, Gary A., Chu, T. Ming

    “…Two distinct monoclonal antibodies (mAbs) were effective in the therapy of breast carcinomas of human origin established and growing in nude mice. Passive…”
    Get full text
    Journal Article
  11. 11

    Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5 by Papsidero, LD, Croghan, GA, Asirwatham, J, Gaeta, J, Abenoza, P, Englander, L, Valenzuela, L

    Published in The American journal of pathology (01-12-1985)
    “…With the use of a murine monoclonal antibody (F5), a panel of metastatic tumors was evaluated for the expression of prostate-specific antigen (PA) under…”
    Get full text
    Journal Article
  12. 12

    Cell and tumor markers' immunohistochemistry in transitional cell carcinoma of the bladder by Lopez-Beltran, A, Croghan, G A, Croghan, I, Gaeta, J F

    Published in Urologia internationalis (01-01-1993)
    “…A wide range of cell and tumor markers including the blood group-related isoantigens A, B, O(H) and T-Ag, the cell markers DCA(F36/22) and epithelial membrane…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels by Hurt, R D, Croghan, G A, Beede, S D, Wolter, T D, Croghan, I T, Patten, C A

    “…To determine the efficacy of nicotine patch therapy in adolescents who want to stop smoking and to assess biochemical markers of smoking and nicotine intake…”
    Get more information
    Journal Article
  15. 15

    Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22 by CROGHAN, G. A, PAPSIDERO, L. D, VALENZUELA, L. A, NEMOTO, T, PENETRANTE, R, MING CHU, T

    Published in Cancer research (Chicago, Ill.) (01-10-1983)
    “…Murine monoclonal antibody F36/22 was derived by immunizing BALB/c mice with human breast cancer cells. This antibody reacts with an antigen located both on…”
    Get full text
    Journal Article
  16. 16

    A Community-Wide Smoking Cessation Program: Quit and Win 1998 in Olmsted County by Croghan, Ivana T., O'Hara, Michael R., Schroeder, Darrell R., Patten, Christi A., Croghan, Gary A., Hays, J.Taylor, Dale, Lowell C., Bowen, Debbie, Kottke, Thomas, Hurt, Richard D.

    Published in Preventive medicine (01-10-2001)
    “…Background. Quit and Win is a community-wide stop smoking contest to help cigarette smokers stop smoking and educate the general public concerning smoking…”
    Get full text
    Journal Article
  17. 17

    Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22 by PAPSIDERO, L. D, NEMOTO, T, CROGHAN, G. A, MING CHU, T

    Published in Cancer research (Chicago, Ill.) (01-10-1984)
    “…A quantitative immunoassay procedure has been constructed to evaluate levels of ductal carcinoma antigen recognized by murine McAb F36/22. Using this method,…”
    Get full text
    Journal Article
  18. 18

    Carbidopa/levodopa for smoking cessation: a pilot study with negative results by Hurt, Richard D., Ahlskog, J. Eric, Croghan, Gary A., Offord, Kenneth P., Wolter, Troy D., Croghan, Ivana T., Moyer, Thomas P.

    Published in Nicotine & tobacco research (01-02-2000)
    “…The mesolimbic dopamine system is thought to be a critical substrate for drugs of addiction including nicotine. Since dopamine may play a critical role in…”
    Get full text
    Journal Article
  19. 19

    Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas by CROGHAN, G. A, WINGATE, M. B, GAMARRA, M, JOHNSON, E, MING CHU, T, ALLEN, H, VALENZUELA, L, TSUKADA, Y, PAPSIDERO, L. D

    Published in Cancer research (Chicago, Ill.) (01-05-1984)
    “…Monoclonal antibody F36/22 recognizes high-molecular-weight glycoprotein components associated with neoplastic development of the ovary. Indirect…”
    Get full text
    Journal Article
  20. 20